These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 7872712
1. Reduced nonspecific steroidal esterase activity in human malignant tumor tissue from liver, colon and breast when compared to peritumoral and normal tissue levels. Lund-Pero M, Jeppson B, Pero RW. Anticancer Res; 1994; 14(6B):2747-53. PubMed ID: 7872712 [Abstract] [Full Text] [Related]
3. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer. Ladner RD, Lynch FJ, Groshen S, Xiong YP, Sherrod A, Caradonna SJ, Stoehlmacher J, Lenz HJ. Cancer Res; 2000 Jul 01; 60(13):3493-503. PubMed ID: 10910061 [Abstract] [Full Text] [Related]
4. Evaluation of telomerase in the development and progression of colon cancer. Boldrini L, Faviana P, Gisfredi S, Zucconi Y, Di Quirico D, Donati V, Berti P, Spisni R, Galleri D, Materazzi G, Basolo F, Miccoli P, Pingitore R, Fontanini G. Int J Mol Med; 2002 Nov 01; 10(5):589-92. PubMed ID: 12373297 [Abstract] [Full Text] [Related]
5. Low colonic glutathione detoxification capacity in patients at risk for colon cancer. Grubben MJ, van den Braak CC, Nagengast FM, Peters WH. Eur J Clin Invest; 2006 Mar 01; 36(3):188-92. PubMed ID: 16506964 [Abstract] [Full Text] [Related]
6. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Engelhardt M, Albanell J, Drullinsky P, Han W, Guillem J, Scher HI, Reuter V, Moore MA. Clin Cancer Res; 1997 Oct 01; 3(10):1849-57. PubMed ID: 9815573 [Abstract] [Full Text] [Related]
13. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sørensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brünner N. Clin Cancer Res; 2002 Jan 01; 8(1):156-64. PubMed ID: 11801553 [Abstract] [Full Text] [Related]
14. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GE. Cancer Res; 1989 Feb 01; 49(3):516-21. PubMed ID: 2910471 [Abstract] [Full Text] [Related]
15. Loss of KAI1 expression in the progression of colorectal cancer. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC. Cancer Res; 1999 Nov 15; 59(22):5724-31. PubMed ID: 10582691 [Abstract] [Full Text] [Related]
16. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Holten-Andersen MN, Murphy G, Nielsen HJ, Pedersen AN, Christensen IJ, Høyer-Hansen G, Brünner N, Stephens RW. Br J Cancer; 1999 May 15; 80(3-4):495-503. PubMed ID: 10408859 [Abstract] [Full Text] [Related]
17. Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. Preuss I, Haas S, Eichhorn U, Eberhagen I, Kaufmann M, Beck T, Eibl RH, Dall P, Bauknecht T, Hengstler J, Wittig BM, Dippold W, Kaina B. Cancer Detect Prev; 1996 May 15; 20(2):130-6. PubMed ID: 8706038 [Abstract] [Full Text] [Related]
19. Histochemically demonstrable protein tyrosine phosphatase in human breast and colorectal cancer: large decrease in its activity in colorectal cancer suggests a tumor suppressor role in colorectal mucosal cells. Partanen S. Anticancer Res; 1996 May 15; 16(2):943-6. PubMed ID: 8687156 [Abstract] [Full Text] [Related]